Medtronic (MDT) Tops Q2 EPS by 22c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Medtronic Reports Second Quarter Fiscal 2021 Financial Results
November 24, 2020 6:45 AM EST- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic
- Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02
DUBLIN, Nov. 24, 2020 /PRNewswire/ --Â Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30, 2020.
The company reported second quarter worldwide revenue of $7.647 billion, a decrease of 0.8 percent as reported and 1.5 percent on an organic basis, which adjusts for the $59 million benefit of foreign currency translation. Unless otherwise stated, all revenue growth rates in this press release... More
